Summary："Phreesia Investors Urged to Take Action in Major Securities Fraud Class Action"LOS ANGELES, June 5,

referrerpolicy="no-referrer"
style="max-width:100%;height:auto;display:block;margin:0 auto;">

"Phreesia Investors Urged to Take Action in Major Securities Fraud Class Action"

LOS ANGELES, June 5, 2026 - The Schall Law Firm, a renowned national shareholder rights litigation firm, is alerting investors to a significant class action lawsuit against Phreesia, Inc. ("Phreesia" or "the Company") (NYSE: PHR), alleging violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934. Investors who purchased Phreesia securities during the specified class period are encouraged to participate in the lawsuit.

Key developments in the case have brought attention to Phreesia's alleged misrepresentations and omissions regarding its business operations and financial performance. According to the lawsuit, Phreesia failed to disclose critical information that artificially inflated its stock price, causing substantial losses for investors. The Schall Law Firm is investigating whether Phreesia's actions constituted securities fraud, and investors are urged to take action to protect their rights.

The healthcare technology industry, in which Phreesia operates, is highly competitive and subject to intense regulatory scrutiny. Analysts are watching the case closely, as a ruling against Phreesia could have far-reaching implications for the industry. The company's alleged misconduct has raised concerns about the accuracy of financial reporting and the effectiveness of internal controls within healthcare technology firms. As the case progresses, it may shed light on the broader industry's practices and potentially lead to increased regulatory oversight.

Looking ahead, investors will be closely monitoring the outcome of the class action lawsuit. A successful claim could result in significant recoveries for affected investors, while a ruling in Phreesia's favor could have implications for the company's reputation and stock performance. As the case unfolds, it is likely to have a ripple effect on the healthcare technology sector, influencing investor confidence and potentially shaping industry standards.

In conclusion, the Phreesia securities fraud class action lawsuit is a significant development that investors should not ignore. The Schall Law Firm encourages affected investors to take action and participate in the lawsuit to protect their rights. As the case progresses, it is likely to have important implications for Phreesia, its investors, and the broader healthcare technology industry. Investors are advised to stay informed about the case and its potential outcomes to make informed investment decisions.